… Focal therapy is widely used for the treatment of breast 2 and kidney 3 cancer, and can …
rates than whole-gland therapy; however, data on focal therapy for prostate cancer are limited. …

… cancers can … prostate cancer being considered for focal therapy by providing additional
evidence that the patient does not harbor an otherwise undetected high-risk, aggressive cancer. …

… TPM still remains necessary before selecting suitable candidates for focal therapy, although
… of MP-MRI in the detection of clinically significant prostate cancer. Guiding Focal Therapy …

… Focal therapy has been introduced for the treatment of localised prostate cancer (PCa).
To provide the necessary data for consistent assessment, all focal therapy trials should be …

… Radical therapy is associated with considerable … cancer control. The arguments for and
against active surveillance and radical therapy are reviewed in this article, with focal therapy …

… Focal therapy of individual prostate cancer lesions, whether multifocal or unifocal, leads to
a … -effects and an encouraging rate of early absence of clinically significant prostate cancer. …

… Focal therapy is a promising, minimally invasive strategy to selectively treat localized prostate
cancer. … the effectiveness of focal therapy in patients with localized prostate cancer in terms …

… Focal therapy (FT) for prostate cancer (PCa) seems to be part of a natural evolution in the …
Focal therapy (FT) has emerged as a middle ground between AS and radical therapy, …

… The oncological effectiveness of focal therapy is yet to be proven in long-term robust trials. …
after focal therapy. When compared to whole gland treatments, focal therapy provides a …

… focal therapy, in men with localized prostate cancer with discussions of the key issues on
trial design. The meeting was supported by a research grant provided by the Medical Research …